Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frans Verhey

Showing results (131-140 of 147) with videos related to

Pageof 15
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 28, 2024
Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF-AD studyRebecca G Smith, Ehsan Pishva, Morteza Kouhsar, et al.
The Lancet. Neurology|September 19, 2019
Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling studyIngrid S van Maurik, Stephanie J Vos, Isabelle Bos, et al.
Brain : a Journal of Neurology|February 20, 2015
Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stageStephanie J B Vos, Frans Verhey, Lutz Frölich, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 5, 2022
Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traitsFahri Küçükali, Alexander Neumann, Jasper Van Dongen, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 1, 2020
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohortDaniel Stamate, Min Kim, Petroula Proitsi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 13, 2019
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohortMin Kim, Stuart Snowden, Tommi Suvitaival, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 1, 2021
Replication study of plasma proteins relating to Alzheimer's pathologyLiu Shi, Laura M Winchester, Sarah Westwood, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 10, 2019
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assayLiu Shi, Sarah Westwood, Alison L Baird, et al.
Journal of Alzheimer'S Disease : JAD|January 28, 2020
Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery CohortSarah Westwood, Alison L Baird, Sneha N Anand, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 28, 2024
Blood-based multivariate methylation risk score for cognitive impairment and dementiaJarno Koetsier, Rachel Cavill, Rick Reijnders, et al.
Pageof 15

Showing results (131-140 of 147) with videos related to

Sort By:
Pageof 15
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 28, 2024
Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF-AD studyRebecca G Smith, Ehsan Pishva, Morteza Kouhsar, et al.
The Lancet. Neurology|September 19, 2019
Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling studyIngrid S van Maurik, Stephanie J Vos, Isabelle Bos, et al.
Brain : a Journal of Neurology|February 20, 2015
Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stageStephanie J B Vos, Frans Verhey, Lutz Frölich, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 5, 2022
Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traitsFahri Küçükali, Alexander Neumann, Jasper Van Dongen, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 1, 2020
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohortDaniel Stamate, Min Kim, Petroula Proitsi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 13, 2019
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohortMin Kim, Stuart Snowden, Tommi Suvitaival, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 1, 2021
Replication study of plasma proteins relating to Alzheimer's pathologyLiu Shi, Laura M Winchester, Sarah Westwood, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 10, 2019
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assayLiu Shi, Sarah Westwood, Alison L Baird, et al.
Journal of Alzheimer'S Disease : JAD|January 28, 2020
Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery CohortSarah Westwood, Alison L Baird, Sneha N Anand, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 28, 2024
Blood-based multivariate methylation risk score for cognitive impairment and dementiaJarno Koetsier, Rachel Cavill, Rick Reijnders, et al.
Pageof 15